ClinicalTrials.govcontrolled
Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101)
ClinicalTrials.gov study NCT01050543. IPD Sharing: YES. Countries: 0. Publications: 1.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8